Safety of Contemporary Heart Failure Therapy in Patients with Continuous-Flow Left Ventricular Assist Devices

Studies on the optimal pharmacological heart failure (HF) therapy after left ventricular assist device (LVAD)b implantation are scarce. From a pathophysiological perspective, neurohormonal blockade offers additional benefits to mechanical unloading. A small-scale study showed a beneficial effect of pharmacological HF therapy on the structure and function of the myocardium after LVAD…

Read the full article here

Related Articles